A detailed history of Starr International CO Inc transactions in Celularity Inc stock. As of the latest transaction made, Starr International CO Inc holds 15,281,389 shares of CELU stock, worth $23.7 Million. This represents 16.9% of its overall portfolio holdings.

Number of Shares
15,281,389
Previous 15,281,389 -0.0%
Holding current value
$23.7 Million
Previous $8.1 Million 58.5%
% of portfolio
16.9%
Previous 35.66%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

BUY
$3.81 - $9.79 $25.3 Million - $65 Million
6,640,694 Added 76.85%
15,281,389 $133 Million
Q4 2021

Jan 27, 2022

BUY
$4.64 - $7.46 $40.1 Million - $64.5 Million
8,640,695 New
8,640,695 $44.2 Million

Others Institutions Holding CELU

About Celularity Inc


  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $221M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Starr International CO Inc Portfolio

Follow Starr International CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Starr International CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Starr International CO Inc with notifications on news.